CreaGen is a US-based premier medicinal chemistry/drug discovery and contract research organization with 23 years of experience in collaborating with more than 50 biotech and pharmaceutical companies and several Federal agencies. Our core expertise is in the synthesis of new chemical entities, preclinical drug discovery research, scale-up synthesis, and early-stage process development. From the earliest stages of drug discovery through IND enabling studies, CreaGen has the technical ability to accommodate a range of needs in the areas of drug discovery, drug product development, and small and large-scale API synthesis. In addition, CreaGen possesses exceptional expertise in non-conventional synthetic modalities such as nucleoside, peptides, and antibody linker chemistry.

CreaGen’s goal is to enable breakthrough research and empower pharmaceutical and biotech companies, academic institutions, and federal research labs to advance the cutting edge of the pharmaceutical landscape.